Processa Pharmaceuticals Inc Net Asset Quality Index
Processa Pharmaceuticals Inc net asset quality index. Processa Pharmaceuticals Inc (PCSA) has a Net Asset Quality Index of 56.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.52 Million minus total liabilities of $1.98 Million yields net assets of $2.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Processa Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Processa Pharmaceuticals Inc (2011–2025)
Net asset quality index of Processa Pharmaceuticals Inc from 2011 to 2025. This chart shows how Processa Pharmaceuticals Inc's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 56.2%, representing net assets of $2.54 Million against total assets of $4.52 Million USD. Check how strategically is Processa Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Processa Pharmaceuticals Inc Net Asset Quality Index by Year (2011–2025)
Processa Pharmaceuticals Inc net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Processa Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Processa Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.4% | $5.58 Million | $7.81 Million | $2.24 Million | ▲ +18.9 pp |
| 2024 | 52.5% | $1.70 Million | $3.23 Million | $1.53 Million | ▼ -33.7 pp |
| 2023 | 86.2% | $4.99 Million | $5.79 Million | $797.48K | ▼ -0.5 pp |
| 2022 | 86.7% | $7.47 Million | $8.62 Million | $1.15 Million | ▼ -9.6 pp |
| 2021 | 96.3% | $25.49 Million | $26.46 Million | $978.40K | ▲ +5.3 pp |
| 2020 | 91.0% | $22.94 Million | $25.21 Million | $2.27 Million | ▲ +17.4 pp |
| 2019 | 73.6% | $8.01 Million | $10.88 Million | $2.87 Million | ▲ +0.2 pp |
| 2018 | 73.4% | $9.70 Million | $13.21 Million | $3.51 Million | ▲ +60.9 pp |
| 2017 | 12.5% | $373.16K | $2.98 Million | $2.61 Million | ▲ +1909.4 pp |
| 2016 | -1896.8% | $-1.98 Million | $104.32K | $2.08 Million | ▲ +0.0 pp |
| 2015 | -1896.8% | $-1.98 Million | $104.32K | $2.08 Million | ▼ -1944.4 pp |
| 2014 | 47.5% | $1.21 Million | $2.54 Million | $1.33 Million | ▼ -9.4 pp |
| 2013 | 56.9% | $1.67 Million | $2.94 Million | $1.27 Million | ▼ -9.1 pp |
| 2012 | 66.0% | $2.56 Million | $3.88 Million | $1.32 Million | ▲ +13.7 pp |
| 2011 | 52.3% | $2.78 Million | $5.31 Million | $2.53 Million | — |